Meet with our product experts in one-on-one virtual sessions
Set Up a MeetingWith over decades of experience, Dr. Reddy's specializes in developing and manufacturing High Potent Active Pharmaceutical Ingredients (HPAPI). We offer HPAPIs manufactured in our FDA inspected cGMP API manufacturing facilities with comprehensive containment processes (up to OEL 0.1µg/m³) and diligent QC/QA.
Reddy’s approach for high-potent APIs involves the following process:
01.Evaluating the hazard of exposure to a compound and calculating the OEL levels
02.Selecting the appropriate containment strategy for development and manufacturing based on scale
03.Choosing proper engineering controls such as ventilation, chemical contaminants, etc.
04.Selecting the appropriate equipment and procedures, including PPE Sampling & weighing, blending, and drying
05.Define Packaging needs to meet the requirements Capsule/Blistering Injectables
From initial stages of development to commercialization, our team of scientists, quality, regulatory, supply chain, and analytical experts work collaboratively to meet our global clients' HPAPI requirements.
As an integrated HPAPI supplier, we have best-in-class cGMP manufacturing facilities for APIs and finished dosage forms. With our integrated R&D capabilities and infrastructure, we are well-positioned to support our customers to bring their products to the market faster. In addition, our rigorous safety, health, and environmental (SHE) practices, together with Occupational Exposure Band (OEB) and Occupational Exposure Limit (OEL) based controls, are established to protect workers, materials, machines, and the environment.
Dr. Reddy’s can handle molecules of OEL up to 0.1 µg/m3 at the following facilities:
Please fill out the following form. We will get back to you shortly.
Top-class safety practices and containment control strategy in place.
No information in this catalog - including any reference to any product or service - constitutes an offer for sale, or be construed as representing an offer for sale. Products protected under valid patents are not offered or supplied for commercial use. However, the research quantities of such products may be offered for the purpose of regulatory submissions, wherever such regulatory exemptions exist. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities. Products protected under valid patents in India are not available for commercial use but would be available for Section 107A purposes.